FTSE 100 news / Companies and sectors / GSK / 11 October 2026

GSK (GSK): news on Sunday 11 October 2026

+7.5 strongly positive

Coverage centred on an $800 million GSK investment bringing 300 jobs, which reads well for the company. GSK also signalled a November start for trials of a subcutaneous Jemperli, while its shares were flat.

What drove it

$800m US investment
Jemperli SC trials
flat share price

The 3 stories

Each headline's own score, strongest first. Links go to the publisher.

+10.0 Shapiro secures $800 million GSK investment, 300 jobs Carlisle Sentinel
$800 million GSK investment and 300 jobs secured in Pennsylvania.
+5.8 Alteogen ALT-B4-based ‘Jemperli SC’ heads into clinical trials, GSK signals November start 더바이오
GSK signals November start for Jemperli subcutaneous clinical trials.
+0.5 GSK stock is unchanged at EUR 20.75 with a weekly high of EUR 20.84 AD HOC NEWS
Share price flat at EUR 20.75, purely factual.

GSK: every day · Pharma and healthcare on 11 October 2026 · FTSE 100 overview for the day